InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Congleton Jon. Officer active across 1 company, notably Mineralys Therapeutics, Inc.. Cumulatively, 2 disclosures have been logged. History available since 30 June 2026. The latest transaction was filed on 13 July 2026 (Notice of proposed sale (Form 144)). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations